Stanley-Laman Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,000
| Closed | -$230K | – | 238 |
|
|
2023
Q1 | $230K | Hold |
4,000
| – | – | 0.04% | 210 |
|
|
2022
Q4 | $224K | Buy |
+4,000
| New | +$224K | 0.04% | 200 |
|
|
2022
Q3 | – | Sell |
-4,000
| Closed | -$216K | – | 257 |
|
|
2022
Q2 | $216K | Hold |
4,000
| – | – | 0.04% | 259 |
|
|
2022
Q1 | $257K | Hold |
4,000
| – | – | 0.04% | 256 |
|
|
2021
Q4 | $268K | Hold |
4,000
| – | – | 0.03% | 246 |
|
|
2021
Q3 | $274K | Hold |
4,000
| – | – | 0.04% | 241 |
|
|
2021
Q2 | $273K | Hold |
4,000
| – | – | 0.04% | 234 |
|
|
2021
Q1 | $276K | Hold |
4,000
| – | – | 0.05% | 226 |
|
|
2020
Q4 | $260K | Buy |
+4,000
| New | +$260K | 0.05% | 223 |
|
|
2020
Q1 | – | Sell |
-4,000
| Closed | -$233K | – | 285 |
|
|
2019
Q4 | $233K | Hold |
4,000
| – | – | 0.06% | 256 |
|
|
2019
Q3 | $240K | Hold |
4,000
| – | – | 0.06% | 247 |
|
|
2019
Q2 | $223K | Hold |
4,000
| – | – | 0.05% | 261 |
|
|
2019
Q1 | $223K | Buy |
+4,000
| New | +$223K | 0.05% | 249 |
|
|
2018
Q4 | – | Sell |
-4,000
| Closed | -$263K | – | 273 |
|
|
2018
Q3 | $263K | Hold |
4,000
| – | – | 0.06% | 199 |
|
|
2018
Q2 | $258K | Hold |
4,000
| – | – | 0.06% | 241 |
|
|
2018
Q1 | $221K | Buy |
+4,000
| New | +$221K | 0.05% | 252 |
|
|
2017
Q4 | – | Sell |
-4,000
| Closed | -$202K | – | 280 |
|
|
2017
Q3 | $202K | Hold |
4,000
| – | – | 0.05% | 198 |
|
|
2017
Q2 | $218K | Buy |
+4,000
| New | +$218K | 0.06% | 191 |
|